Global T-Cell Therapy Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for T-Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding T-Cell Therapy.
The T-Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global T-Cell Therapy market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the T-Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of T-Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The T-Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global T-Cell Therapy market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the T-Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
- Gilead Sciences, Inc.
- Sorrento Therapeutics
- Fate Therapeutics Inc.
- Novartis International AG
- AbbVie Inc.
- Adaptimmune Therapeutics PLC
- Bluebird Bio
- TCR2 Therapeutics, Inc.
- Pfizer Inc.
- DiaCarta, Inc.
- CAR T Cell Therapy
- TCR Therapy
- TIL Therapy
- Hospitals
- Clinics & Ambulatory Centers
- Cancer Research Institutes
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of T-Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global T-Cell Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 CAR T Cell Therapy
1.2.3 TCR Therapy
1.2.4 TIL Therapy
1.3 Market by Application
1.3.1 Global T-Cell Therapy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics & Ambulatory Centers
1.3.4 Cancer Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global T-Cell Therapy Market Perspective (2018-2029)
2.2 T-Cell Therapy Growth Trends by Region
2.2.1 Global T-Cell Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 T-Cell Therapy Historic Market Size by Region (2018-2023)
2.2.3 T-Cell Therapy Forecasted Market Size by Region (2024-2029)
2.3 T-Cell Therapy Market Dynamics
2.3.1 T-Cell Therapy Industry Trends
2.3.2 T-Cell Therapy Market Drivers
2.3.3 T-Cell Therapy Market Challenges
2.3.4 T-Cell Therapy Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top T-Cell Therapy Players by Revenue
3.1.1 Global Top T-Cell Therapy Players by Revenue (2018-2023)
3.1.2 Global T-Cell Therapy Revenue Market Share by Players (2018-2023)
3.2 Global T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by T-Cell Therapy Revenue
3.4 Global T-Cell Therapy Market Concentration Ratio
3.4.1 Global T-Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by T-Cell Therapy Revenue in 2022
3.5 T-Cell Therapy Key Players Head office and Area Served
3.6 Key Players T-Cell Therapy Product Solution and Service
3.7 Date of Enter into T-Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 T-CELL THERAPY BREAKDOWN DATA BY TYPE
4.1 Global T-Cell Therapy Historic Market Size by Type (2018-2023)
4.2 Global T-Cell Therapy Forecasted Market Size by Type (2024-2029)
5 T-CELL THERAPY BREAKDOWN DATA BY APPLICATION
5.1 Global T-Cell Therapy Historic Market Size by Application (2018-2023)
5.2 Global T-Cell Therapy Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America T-Cell Therapy Market Size (2018-2029)
6.2 North America T-Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America T-Cell Therapy Market Size by Country (2018-2023)
6.4 North America T-Cell Therapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe T-Cell Therapy Market Size (2018-2029)
7.2 Europe T-Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe T-Cell Therapy Market Size by Country (2018-2023)
7.4 Europe T-Cell Therapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific T-Cell Therapy Market Size (2018-2029)
8.2 Asia-Pacific T-Cell Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific T-Cell Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific T-Cell Therapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America T-Cell Therapy Market Size (2018-2029)
9.2 Latin America T-Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America T-Cell Therapy Market Size by Country (2018-2023)
9.4 Latin America T-Cell Therapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa T-Cell Therapy Market Size (2018-2029)
10.2 Middle East & Africa T-Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa T-Cell Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa T-Cell Therapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Gilead Sciences, Inc.
11.1.1 Gilead Sciences, Inc. Company Detail
11.1.2 Gilead Sciences, Inc. Business Overview
11.1.3 Gilead Sciences, Inc. T-Cell Therapy Introduction
11.1.4 Gilead Sciences, Inc. Revenue in T-Cell Therapy Business (2018-2023)
11.1.5 Gilead Sciences, Inc. Recent Development
11.2 Sorrento Therapeutics
11.2.1 Sorrento Therapeutics Company Detail
11.2.2 Sorrento Therapeutics Business Overview
11.2.3 Sorrento Therapeutics T-Cell Therapy Introduction
11.2.4 Sorrento Therapeutics Revenue in T-Cell Therapy Business (2018-2023)
11.2.5 Sorrento Therapeutics Recent Development
11.3 Fate Therapeutics Inc.
11.3.1 Fate Therapeutics Inc. Company Detail
11.3.2 Fate Therapeutics Inc. Business Overview
11.3.3 Fate Therapeutics Inc. T-Cell Therapy Introduction
11.3.4 Fate Therapeutics Inc. Revenue in T-Cell Therapy Business (2018-2023)
11.3.5 Fate Therapeutics Inc. Recent Development
11.4 Novartis International AG
11.4.1 Novartis International AG Company Detail
11.4.2 Novartis International AG Business Overview
11.4.3 Novartis International AG T-Cell Therapy Introduction
11.4.4 Novartis International AG Revenue in T-Cell Therapy Business (2018-2023)
11.4.5 Novartis International AG Recent Development
11.5 AbbVie Inc.
11.5.1 AbbVie Inc. Company Detail
11.5.2 AbbVie Inc. Business Overview
11.5.3 AbbVie Inc. T-Cell Therapy Introduction
11.5.4 AbbVie Inc. Revenue in T-Cell Therapy Business (2018-2023)
11.5.5 AbbVie Inc. Recent Development
11.6 Adaptimmune Therapeutics PLC
11.6.1 Adaptimmune Therapeutics PLC Company Detail
11.6.2 Adaptimmune Therapeutics PLC Business Overview
11.6.3 Adaptimmune Therapeutics PLC T-Cell Therapy Introduction
11.6.4 Adaptimmune Therapeutics PLC Revenue in T-Cell Therapy Business (2018-2023)
11.6.5 Adaptimmune Therapeutics PLC Recent Development
11.7 Bluebird Bio
11.7.1 Bluebird Bio Company Detail
11.7.2 Bluebird Bio Business Overview
11.7.3 Bluebird Bio T-Cell Therapy Introduction
11.7.4 Bluebird Bio Revenue in T-Cell Therapy Business (2018-2023)
11.7.5 Bluebird Bio Recent Development
11.8 TCR2 Therapeutics, Inc.
11.8.1 TCR2 Therapeutics, Inc. Company Detail
11.8.2 TCR2 Therapeutics, Inc. Business Overview
11.8.3 TCR2 Therapeutics, Inc. T-Cell Therapy Introduction
11.8.4 TCR2 Therapeutics, Inc. Revenue in T-Cell Therapy Business (2018-2023)
11.8.5 TCR2 Therapeutics, Inc. Recent Development
11.9 Pfizer Inc.
11.9.1 Pfizer Inc. Company Detail
11.9.2 Pfizer Inc. Business Overview
11.9.3 Pfizer Inc. T-Cell Therapy Introduction
11.9.4 Pfizer Inc. Revenue in T-Cell Therapy Business (2018-2023)
11.9.5 Pfizer Inc. Recent Development
11.10 DiaCarta, Inc.
11.10.1 DiaCarta, Inc. Company Detail
11.10.2 DiaCarta, Inc. Business Overview
11.10.3 DiaCarta, Inc. T-Cell Therapy Introduction
11.10.4 DiaCarta, Inc. Revenue in T-Cell Therapy Business (2018-2023)
11.10.5 DiaCarta, Inc. Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global T-Cell Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 CAR T Cell Therapy
1.2.3 TCR Therapy
1.2.4 TIL Therapy
1.3 Market by Application
1.3.1 Global T-Cell Therapy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics & Ambulatory Centers
1.3.4 Cancer Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global T-Cell Therapy Market Perspective (2018-2029)
2.2 T-Cell Therapy Growth Trends by Region
2.2.1 Global T-Cell Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 T-Cell Therapy Historic Market Size by Region (2018-2023)
2.2.3 T-Cell Therapy Forecasted Market Size by Region (2024-2029)
2.3 T-Cell Therapy Market Dynamics
2.3.1 T-Cell Therapy Industry Trends
2.3.2 T-Cell Therapy Market Drivers
2.3.3 T-Cell Therapy Market Challenges
2.3.4 T-Cell Therapy Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top T-Cell Therapy Players by Revenue
3.1.1 Global Top T-Cell Therapy Players by Revenue (2018-2023)
3.1.2 Global T-Cell Therapy Revenue Market Share by Players (2018-2023)
3.2 Global T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by T-Cell Therapy Revenue
3.4 Global T-Cell Therapy Market Concentration Ratio
3.4.1 Global T-Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by T-Cell Therapy Revenue in 2022
3.5 T-Cell Therapy Key Players Head office and Area Served
3.6 Key Players T-Cell Therapy Product Solution and Service
3.7 Date of Enter into T-Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 T-CELL THERAPY BREAKDOWN DATA BY TYPE
4.1 Global T-Cell Therapy Historic Market Size by Type (2018-2023)
4.2 Global T-Cell Therapy Forecasted Market Size by Type (2024-2029)
5 T-CELL THERAPY BREAKDOWN DATA BY APPLICATION
5.1 Global T-Cell Therapy Historic Market Size by Application (2018-2023)
5.2 Global T-Cell Therapy Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America T-Cell Therapy Market Size (2018-2029)
6.2 North America T-Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America T-Cell Therapy Market Size by Country (2018-2023)
6.4 North America T-Cell Therapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe T-Cell Therapy Market Size (2018-2029)
7.2 Europe T-Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe T-Cell Therapy Market Size by Country (2018-2023)
7.4 Europe T-Cell Therapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific T-Cell Therapy Market Size (2018-2029)
8.2 Asia-Pacific T-Cell Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific T-Cell Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific T-Cell Therapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America T-Cell Therapy Market Size (2018-2029)
9.2 Latin America T-Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America T-Cell Therapy Market Size by Country (2018-2023)
9.4 Latin America T-Cell Therapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa T-Cell Therapy Market Size (2018-2029)
10.2 Middle East & Africa T-Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa T-Cell Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa T-Cell Therapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Gilead Sciences, Inc.
11.1.1 Gilead Sciences, Inc. Company Detail
11.1.2 Gilead Sciences, Inc. Business Overview
11.1.3 Gilead Sciences, Inc. T-Cell Therapy Introduction
11.1.4 Gilead Sciences, Inc. Revenue in T-Cell Therapy Business (2018-2023)
11.1.5 Gilead Sciences, Inc. Recent Development
11.2 Sorrento Therapeutics
11.2.1 Sorrento Therapeutics Company Detail
11.2.2 Sorrento Therapeutics Business Overview
11.2.3 Sorrento Therapeutics T-Cell Therapy Introduction
11.2.4 Sorrento Therapeutics Revenue in T-Cell Therapy Business (2018-2023)
11.2.5 Sorrento Therapeutics Recent Development
11.3 Fate Therapeutics Inc.
11.3.1 Fate Therapeutics Inc. Company Detail
11.3.2 Fate Therapeutics Inc. Business Overview
11.3.3 Fate Therapeutics Inc. T-Cell Therapy Introduction
11.3.4 Fate Therapeutics Inc. Revenue in T-Cell Therapy Business (2018-2023)
11.3.5 Fate Therapeutics Inc. Recent Development
11.4 Novartis International AG
11.4.1 Novartis International AG Company Detail
11.4.2 Novartis International AG Business Overview
11.4.3 Novartis International AG T-Cell Therapy Introduction
11.4.4 Novartis International AG Revenue in T-Cell Therapy Business (2018-2023)
11.4.5 Novartis International AG Recent Development
11.5 AbbVie Inc.
11.5.1 AbbVie Inc. Company Detail
11.5.2 AbbVie Inc. Business Overview
11.5.3 AbbVie Inc. T-Cell Therapy Introduction
11.5.4 AbbVie Inc. Revenue in T-Cell Therapy Business (2018-2023)
11.5.5 AbbVie Inc. Recent Development
11.6 Adaptimmune Therapeutics PLC
11.6.1 Adaptimmune Therapeutics PLC Company Detail
11.6.2 Adaptimmune Therapeutics PLC Business Overview
11.6.3 Adaptimmune Therapeutics PLC T-Cell Therapy Introduction
11.6.4 Adaptimmune Therapeutics PLC Revenue in T-Cell Therapy Business (2018-2023)
11.6.5 Adaptimmune Therapeutics PLC Recent Development
11.7 Bluebird Bio
11.7.1 Bluebird Bio Company Detail
11.7.2 Bluebird Bio Business Overview
11.7.3 Bluebird Bio T-Cell Therapy Introduction
11.7.4 Bluebird Bio Revenue in T-Cell Therapy Business (2018-2023)
11.7.5 Bluebird Bio Recent Development
11.8 TCR2 Therapeutics, Inc.
11.8.1 TCR2 Therapeutics, Inc. Company Detail
11.8.2 TCR2 Therapeutics, Inc. Business Overview
11.8.3 TCR2 Therapeutics, Inc. T-Cell Therapy Introduction
11.8.4 TCR2 Therapeutics, Inc. Revenue in T-Cell Therapy Business (2018-2023)
11.8.5 TCR2 Therapeutics, Inc. Recent Development
11.9 Pfizer Inc.
11.9.1 Pfizer Inc. Company Detail
11.9.2 Pfizer Inc. Business Overview
11.9.3 Pfizer Inc. T-Cell Therapy Introduction
11.9.4 Pfizer Inc. Revenue in T-Cell Therapy Business (2018-2023)
11.9.5 Pfizer Inc. Recent Development
11.10 DiaCarta, Inc.
11.10.1 DiaCarta, Inc. Company Detail
11.10.2 DiaCarta, Inc. Business Overview
11.10.3 DiaCarta, Inc. T-Cell Therapy Introduction
11.10.4 DiaCarta, Inc. Revenue in T-Cell Therapy Business (2018-2023)
11.10.5 DiaCarta, Inc. Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global T-Cell Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of CAR T Cell Therapy
Table 3. Key Players of TCR Therapy
Table 4. Key Players of TIL Therapy
Table 5. Global T-Cell Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global T-Cell Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global T-Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global T-Cell Therapy Market Share by Region (2018-2023)
Table 9. Global T-Cell Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global T-Cell Therapy Market Share by Region (2024-2029)
Table 11. T-Cell Therapy Market Trends
Table 12. T-Cell Therapy Market Drivers
Table 13. T-Cell Therapy Market Challenges
Table 14. T-Cell Therapy Market Restraints
Table 15. Global T-Cell Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global T-Cell Therapy Market Share by Players (2018-2023)
Table 17. Global Top T-Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T-Cell Therapy as of 2022)
Table 18. Ranking of Global Top T-Cell Therapy Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by T-Cell Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players T-Cell Therapy Product Solution and Service
Table 22. Date of Enter into T-Cell Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global T-Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global T-Cell Therapy Revenue Market Share by Type (2018-2023)
Table 26. Global T-Cell Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global T-Cell Therapy Revenue Market Share by Type (2024-2029)
Table 28. Global T-Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global T-Cell Therapy Revenue Market Share by Application (2018-2023)
Table 30. Global T-Cell Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global T-Cell Therapy Revenue Market Share by Application (2024-2029)
Table 32. North America T-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America T-Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America T-Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe T-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe T-Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe T-Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific T-Cell Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific T-Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific T-Cell Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America T-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America T-Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America T-Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa T-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa T-Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa T-Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 47. Gilead Sciences, Inc. Company Detail
Table 48. Gilead Sciences, Inc. Business Overview
Table 49. Gilead Sciences, Inc. T-Cell Therapy Product
Table 50. Gilead Sciences, Inc. Revenue in T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 51. Gilead Sciences, Inc. Recent Development
Table 52. Sorrento Therapeutics Company Detail
Table 53. Sorrento Therapeutics Business Overview
Table 54. Sorrento Therapeutics T-Cell Therapy Product
Table 55. Sorrento Therapeutics Revenue in T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 56. Sorrento Therapeutics Recent Development
Table 57. Fate Therapeutics Inc. Company Detail
Table 58. Fate Therapeutics Inc. Business Overview
Table 59. Fate Therapeutics Inc. T-Cell Therapy Product
Table 60. Fate Therapeutics Inc. Revenue in T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 61. Fate Therapeutics Inc. Recent Development
Table 62. Novartis International AG Company Detail
Table 63. Novartis International AG Business Overview
Table 64. Novartis International AG T-Cell Therapy Product
Table 65. Novartis International AG Revenue in T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 66. Novartis International AG Recent Development
Table 67. AbbVie Inc. Company Detail
Table 68. AbbVie Inc. Business Overview
Table 69. AbbVie Inc. T-Cell Therapy Product
Table 70. AbbVie Inc. Revenue in T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 71. AbbVie Inc. Recent Development
Table 72. Adaptimmune Therapeutics PLC Company Detail
Table 73. Adaptimmune Therapeutics PLC Business Overview
Table 74. Adaptimmune Therapeutics PLC T-Cell Therapy Product
Table 75. Adaptimmune Therapeutics PLC Revenue in T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 76. Adaptimmune Therapeutics PLC Recent Development
Table 77. Bluebird Bio Company Detail
Table 78. Bluebird Bio Business Overview
Table 79. Bluebird Bio T-Cell Therapy Product
Table 80. Bluebird Bio Revenue in T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 81. Bluebird Bio Recent Development
Table 82. TCR2 Therapeutics, Inc. Company Detail
Table 83. TCR2 Therapeutics, Inc. Business Overview
Table 84. TCR2 Therapeutics, Inc. T-Cell Therapy Product
Table 85. TCR2 Therapeutics, Inc. Revenue in T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 86. TCR2 Therapeutics, Inc. Recent Development
Table 87. Pfizer Inc. Company Detail
Table 88. Pfizer Inc. Business Overview
Table 89. Pfizer Inc. T-Cell Therapy Product
Table 90. Pfizer Inc. Revenue in T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 91. Pfizer Inc. Recent Development
Table 92. DiaCarta, Inc. Company Detail
Table 93. DiaCarta, Inc. Business Overview
Table 94. DiaCarta, Inc. T-Cell Therapy Product
Table 95. DiaCarta, Inc. Revenue in T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 96. DiaCarta, Inc. Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 1. Global T-Cell Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of CAR T Cell Therapy
Table 3. Key Players of TCR Therapy
Table 4. Key Players of TIL Therapy
Table 5. Global T-Cell Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global T-Cell Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global T-Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global T-Cell Therapy Market Share by Region (2018-2023)
Table 9. Global T-Cell Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global T-Cell Therapy Market Share by Region (2024-2029)
Table 11. T-Cell Therapy Market Trends
Table 12. T-Cell Therapy Market Drivers
Table 13. T-Cell Therapy Market Challenges
Table 14. T-Cell Therapy Market Restraints
Table 15. Global T-Cell Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global T-Cell Therapy Market Share by Players (2018-2023)
Table 17. Global Top T-Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T-Cell Therapy as of 2022)
Table 18. Ranking of Global Top T-Cell Therapy Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by T-Cell Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players T-Cell Therapy Product Solution and Service
Table 22. Date of Enter into T-Cell Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global T-Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global T-Cell Therapy Revenue Market Share by Type (2018-2023)
Table 26. Global T-Cell Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global T-Cell Therapy Revenue Market Share by Type (2024-2029)
Table 28. Global T-Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global T-Cell Therapy Revenue Market Share by Application (2018-2023)
Table 30. Global T-Cell Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global T-Cell Therapy Revenue Market Share by Application (2024-2029)
Table 32. North America T-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America T-Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America T-Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe T-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe T-Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe T-Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific T-Cell Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific T-Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific T-Cell Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America T-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America T-Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America T-Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa T-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa T-Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa T-Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 47. Gilead Sciences, Inc. Company Detail
Table 48. Gilead Sciences, Inc. Business Overview
Table 49. Gilead Sciences, Inc. T-Cell Therapy Product
Table 50. Gilead Sciences, Inc. Revenue in T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 51. Gilead Sciences, Inc. Recent Development
Table 52. Sorrento Therapeutics Company Detail
Table 53. Sorrento Therapeutics Business Overview
Table 54. Sorrento Therapeutics T-Cell Therapy Product
Table 55. Sorrento Therapeutics Revenue in T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 56. Sorrento Therapeutics Recent Development
Table 57. Fate Therapeutics Inc. Company Detail
Table 58. Fate Therapeutics Inc. Business Overview
Table 59. Fate Therapeutics Inc. T-Cell Therapy Product
Table 60. Fate Therapeutics Inc. Revenue in T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 61. Fate Therapeutics Inc. Recent Development
Table 62. Novartis International AG Company Detail
Table 63. Novartis International AG Business Overview
Table 64. Novartis International AG T-Cell Therapy Product
Table 65. Novartis International AG Revenue in T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 66. Novartis International AG Recent Development
Table 67. AbbVie Inc. Company Detail
Table 68. AbbVie Inc. Business Overview
Table 69. AbbVie Inc. T-Cell Therapy Product
Table 70. AbbVie Inc. Revenue in T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 71. AbbVie Inc. Recent Development
Table 72. Adaptimmune Therapeutics PLC Company Detail
Table 73. Adaptimmune Therapeutics PLC Business Overview
Table 74. Adaptimmune Therapeutics PLC T-Cell Therapy Product
Table 75. Adaptimmune Therapeutics PLC Revenue in T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 76. Adaptimmune Therapeutics PLC Recent Development
Table 77. Bluebird Bio Company Detail
Table 78. Bluebird Bio Business Overview
Table 79. Bluebird Bio T-Cell Therapy Product
Table 80. Bluebird Bio Revenue in T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 81. Bluebird Bio Recent Development
Table 82. TCR2 Therapeutics, Inc. Company Detail
Table 83. TCR2 Therapeutics, Inc. Business Overview
Table 84. TCR2 Therapeutics, Inc. T-Cell Therapy Product
Table 85. TCR2 Therapeutics, Inc. Revenue in T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 86. TCR2 Therapeutics, Inc. Recent Development
Table 87. Pfizer Inc. Company Detail
Table 88. Pfizer Inc. Business Overview
Table 89. Pfizer Inc. T-Cell Therapy Product
Table 90. Pfizer Inc. Revenue in T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 91. Pfizer Inc. Recent Development
Table 92. DiaCarta, Inc. Company Detail
Table 93. DiaCarta, Inc. Business Overview
Table 94. DiaCarta, Inc. T-Cell Therapy Product
Table 95. DiaCarta, Inc. Revenue in T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 96. DiaCarta, Inc. Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global T-Cell Therapy Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global T-Cell Therapy Market Share by Type: 2022 VS 2029
Figure 3. CAR T Cell Therapy Features
Figure 4. TCR Therapy Features
Figure 5. TIL Therapy Features
Figure 6. Global T-Cell Therapy Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global T-Cell Therapy Market Share by Application: 2022 VS 2029
Figure 8. Hospitals Case Studies
Figure 9. Clinics & Ambulatory Centers Case Studies
Figure 10. Cancer Research Institutes Case Studies
Figure 11. Others Case Studies
Figure 12. T-Cell Therapy Report Years Considered
Figure 13. Global T-Cell Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global T-Cell Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global T-Cell Therapy Market Share by Region: 2022 VS 2029
Figure 16. Global T-Cell Therapy Market Share by Players in 2022
Figure 17. Global Top T-Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T-Cell Therapy as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by T-Cell Therapy Revenue in 2022
Figure 19. North America T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America T-Cell Therapy Market Share by Country (2018-2029)
Figure 21. United States T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe T-Cell Therapy Market Share by Country (2018-2029)
Figure 25. Germany T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific T-Cell Therapy Market Share by Region (2018-2029)
Figure 33. China T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America T-Cell Therapy Market Share by Country (2018-2029)
Figure 41. Mexico T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa T-Cell Therapy Market Share by Country (2018-2029)
Figure 45. Turkey T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Gilead Sciences, Inc. Revenue Growth Rate in T-Cell Therapy Business (2018-2023)
Figure 48. Sorrento Therapeutics Revenue Growth Rate in T-Cell Therapy Business (2018-2023)
Figure 49. Fate Therapeutics Inc. Revenue Growth Rate in T-Cell Therapy Business (2018-2023)
Figure 50. Novartis International AG Revenue Growth Rate in T-Cell Therapy Business (2018-2023)
Figure 51. AbbVie Inc. Revenue Growth Rate in T-Cell Therapy Business (2018-2023)
Figure 52. Adaptimmune Therapeutics PLC Revenue Growth Rate in T-Cell Therapy Business (2018-2023)
Figure 53. Bluebird Bio Revenue Growth Rate in T-Cell Therapy Business (2018-2023)
Figure 54. TCR2 Therapeutics, Inc. Revenue Growth Rate in T-Cell Therapy Business (2018-2023)
Figure 55. Pfizer Inc. Revenue Growth Rate in T-Cell Therapy Business (2018-2023)
Figure 56. DiaCarta, Inc. Revenue Growth Rate in T-Cell Therapy Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Figure 1. Global T-Cell Therapy Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global T-Cell Therapy Market Share by Type: 2022 VS 2029
Figure 3. CAR T Cell Therapy Features
Figure 4. TCR Therapy Features
Figure 5. TIL Therapy Features
Figure 6. Global T-Cell Therapy Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global T-Cell Therapy Market Share by Application: 2022 VS 2029
Figure 8. Hospitals Case Studies
Figure 9. Clinics & Ambulatory Centers Case Studies
Figure 10. Cancer Research Institutes Case Studies
Figure 11. Others Case Studies
Figure 12. T-Cell Therapy Report Years Considered
Figure 13. Global T-Cell Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global T-Cell Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global T-Cell Therapy Market Share by Region: 2022 VS 2029
Figure 16. Global T-Cell Therapy Market Share by Players in 2022
Figure 17. Global Top T-Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T-Cell Therapy as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by T-Cell Therapy Revenue in 2022
Figure 19. North America T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America T-Cell Therapy Market Share by Country (2018-2029)
Figure 21. United States T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe T-Cell Therapy Market Share by Country (2018-2029)
Figure 25. Germany T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific T-Cell Therapy Market Share by Region (2018-2029)
Figure 33. China T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America T-Cell Therapy Market Share by Country (2018-2029)
Figure 41. Mexico T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa T-Cell Therapy Market Share by Country (2018-2029)
Figure 45. Turkey T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Gilead Sciences, Inc. Revenue Growth Rate in T-Cell Therapy Business (2018-2023)
Figure 48. Sorrento Therapeutics Revenue Growth Rate in T-Cell Therapy Business (2018-2023)
Figure 49. Fate Therapeutics Inc. Revenue Growth Rate in T-Cell Therapy Business (2018-2023)
Figure 50. Novartis International AG Revenue Growth Rate in T-Cell Therapy Business (2018-2023)
Figure 51. AbbVie Inc. Revenue Growth Rate in T-Cell Therapy Business (2018-2023)
Figure 52. Adaptimmune Therapeutics PLC Revenue Growth Rate in T-Cell Therapy Business (2018-2023)
Figure 53. Bluebird Bio Revenue Growth Rate in T-Cell Therapy Business (2018-2023)
Figure 54. TCR2 Therapeutics, Inc. Revenue Growth Rate in T-Cell Therapy Business (2018-2023)
Figure 55. Pfizer Inc. Revenue Growth Rate in T-Cell Therapy Business (2018-2023)
Figure 56. DiaCarta, Inc. Revenue Growth Rate in T-Cell Therapy Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
